Alpna Seth's Net Worth
$4.65 Million
Who is Alpna Seth?
Alpna Seth has an estimated net worth of $4.65 Million. This is based on reported shares across multiple companies, which include SEATTLE GENETICS INC /WA, BIO-TECHNE Corp, and Keros Therapeutics, Inc..
SEC CIK
Alpna Seth's CIK is 0001721020
Past Insider Trading and Trends
2020 was Alpna Seth's most active year for acquiring shares with 6 total transactions. Alpna Seth's most active month to acquire stocks was the month of September. 2023 was Alpna Seth's most active year for disposing of shares, totalling 7 transactions. Alpna Seth's most active month to dispose stocks was the month of November. 2020 saw Alpna Seth paying a total of $732,117.57 for 11,427 shares, this is the most they've acquired in one year. In 2023 Alpna Seth cashed out on 46,594 shares for a total of $2,966,237.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SEATTLE GENETICS INC /WA (SGEN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -12.95K |
$229.00 | -$2,966,237.00 |
0
|
Dec 14
| |||
Form 4
| +15.78% | 2.04K |
—
|
—
| 15K |
May 31
| |||
Form 4
| +13.13% | 1.5K |
—
|
—
| 12.95K |
May 13
| |||
Form 4
| +13.95% | 1.4K |
—
|
—
| 11.45K |
May 14
| |||
Form 4
| +15.32% | 1.33K |
—
|
—
| 10.05K |
May 15
| |||
Form 4
| +51.53% | 2.96K |
—
|
—
| 8.71K |
May 20
| |||
Form 4
|
∞
| 5.75K |
—
|
—
| 5.75K |
Mar 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIO-TECHNE Corp (TECH) Snapshot price: $71.49
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.88% | 1.46K |
—
|
—
| 13.77K |
Oct 24
| |||
Form 4
| +15.21% | 1.63K |
—
|
—
| 12.31K |
Oct 26
| |||
Form 4
| +14.49% | 338 |
—
|
—
| 2.67K |
Oct 27
| |||
Form 4
| +9.07% | 194 |
—
|
—
| 2.33K |
Oct 28
| |||
Form 4
|
—
|
0
|
$226.19 | -$808,049.10 | 2.14K |
Nov 9
| |||
Form 4
| +22.37% | 391 |
—
|
—
| 2.14K |
Oct 29
| |||
Form 4
| +39.51% | 495 |
—
|
—
| 1.75K |
Oct 24
| |||
Form 4
| +69.55% | 514 |
—
|
—
| 1.25K |
Oct 25
| |||
Form 4
|
∞
| 739 |
—
|
—
| 739 |
Oct 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Keros Therapeutics, Inc. (KROS) Snapshot price: $52.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||